Özlen Atuğ
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Gastroenterology top 10%
Papers in
-
- Liver Disease Diagnosis and Treatment 6
- Hepatitis B Virus Studies 2
- Genetics 8
- Inflammatory Bowel Disease 7
- Co-authors
- Yusuf Yılmaz (14 shared papers)Neşe İmeryüz (22 shared papers)Fatih Eren (10 shared papers)Enver Dolar (4 shared papers)Engı̇n Ulukaya (3 shared papers)Haluk Tarık Kani (17 shared papers)Nurdan Tözün (12 shared papers)Ramazan Kurt (3 shared papers)
- Journals
- Journal of Crohn s and Colitis (4 papers)European Journal of Gastroenterology & Hepatology (3 papers)Digestive Diseases and Sciences (3 papers)Annals of the Rheumatic Diseases (2 papers)Journal of Hepatology (2 papers)
- Partner nations
- TürkiyeUnited StatesRwanda
In The Last Decade
Özlen Atuğ
47 papers receiving 679 citations
Peers
Comparison fields: 5 of 84
- Hepatology 66
- Gastroenterology 39
- Epidemiology 239
- Endocrinology, Diabetes and Metabolism 95
- Clinical Biochemistry 32
Countries citing papers authored by Özlen Atuğ
This map shows the geographic impact of Özlen Atuğ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özlen Atuğ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özlen Atuğ more than expected).
Fields of papers citing papers by Özlen Atuğ
This network shows the impact of papers produced by Özlen Atuğ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özlen Atuğ. The network helps show where Özlen Atuğ may publish in the future.
Co-authors
The 25 scholars most cited alongside Özlen Atuğ, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 57 | |
| 2 | 2008 | 54 | |
| 3 | 2009 | 53 | |
| 4 | 2009 | 52 | |
| 5 | 2009 | 48 | |
| 6 | 2012 | 47 | |
| 7 | 2011 | 45 | |
| 8 | 2022 | 24 | |
| 9 | 2011 | 24 | |
| 10 | 2009 | 23 | |
| 11 | 2012 | 22 | |
| 12 | 2009 | 19 | |
| 13 | Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease. | 2009 | 18 |
| 14 | 2010 | 17 | |
| 15 | 2016 | 15 | |
| 16 | 2020 | 14 | |
| 17 | 2009 | 13 | |
| 18 | 2019 | 12 | |
| 19 | 2011 | 12 | |
| 20 | 2010 | 11 |
About Özlen Atuğ
Özlen Atuğ is a scholar working on Epidemiology, Genetics, Hepatology, Surgery and Molecular Biology, having authored 53 papers that have together received 694 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (7 papers), Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (5 papers), Hepatitis B Virus Studies (2 papers), Spondyloarthritis Studies and Treatments (2 papers), Fibroblast Growth Factor Research (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Gastroesophageal reflux and treatments (2 papers). The work is most often cited by research in Hepatology (66 citations), Gastroenterology (39 citations), Epidemiology (239 citations), Endocrinology, Diabetes and Metabolism (95 citations) and Clinical Biochemistry (32 citations). Özlen Atuğ has collaborated with scholars based in Türkiye, United States and Rwanda. Frequent co-authors include Yusuf Yılmaz, Neşe İmeryüz, Fatih Eren, Enver Dolar, Engı̇n Ulukaya, Haluk Tarık Kani, Nurdan Tözün, Ramazan Kurt, Yeşim Özen Alahdab and Osman Özdoğan. Their work appears in journals such as Journal of Crohn s and Colitis, European Journal of Gastroenterology & Hepatology, Digestive Diseases and Sciences, Annals of the Rheumatic Diseases and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.